Obesity Enables NLRP3 Activation and Induces Myocardial Fibrosis via Hyperacetylation of HADHa
- 25 August 2023
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 72 (11) , 1597-1608
Abstract
Obesity increases the risk of myocardial fibrosis, a pathological change in most heart diseases, but the mechanism has not been fully elucidated. Here, we found that mice with high-fat diet–induced obesity had more severe myocardial fibrosis than control mice under normal and ischemia/reperfusion (I/R) conditions, which could be alleviated by neutralizing antibodies against interleukin (IL)-1β and IL-18, downstream products of the nucleotide-binding oligomerization-like receptor protein 3 (NLRP3) inflammasome, and the NLRP3 inhibitor MCC950. Mechanistically, mitochondrial hyperacetylation in obese mouse hearts recruited apoptosis-associated speck-like protein containing a CARD (ASC) to mitochondria and thus facilitated NLRP3 inflammasome assembly. Acetylation of K255 on hydroxyl-CoA dehydrogenase α subunit (HADHa) was identified to trigger the mitochondrial localization of ASC. Blockade of HADHa-K255 acetylation downregulated mitochondrial ASC, suppressed the NLRP3 inflammasome, and attenuated post-I/R myocardial fibrosis in obese mouse hearts. In obese human patients, the extent of myocardial fibrosis according to T1 MRI was positively correlated with the plasma levels of IL-1β and IL-18, supporting the connection of NLRP3 inflammation to obesity-induced myocardial fibrosis. In conclusion, our study demonstrates that the heart is susceptible to fibrosis under obesity through hyperacetylated HADHa-mediated activation of the NLRP3 inflammasome. Article Highlights:Keywords
All Related Versions
Funding Information
- Natural Science Foundation of Sichuan Province (2023NSFSC1633)
- National Natural Science Foundation of China (81970715, 82370260, 82300916)
- Yunnan Provincial Cardiovascular Disease Clinical Medical Center Project (2022YFKY078)
- Key Research and Development Program of Sichuan Province (2022YFS0132, 2022YFS0198)
This publication has 38 references indexed in Scilit:
- The global burden of metabolic disease: Data from 2000 to 2019Cell Metabolism, 2023
- Bilirubin stabilizes the mitochondrial membranes during NLRP3 inflammasome activationBiochemical Pharmacology, 2022
- The Leading Causes of Death in the US for 2020JAMA, 2021
- NLRP3 inflammasome in cardiovascular diseases: Pathophysiological and pharmacological implicationsMedicinal Research Reviews, 2021
- NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseasesClinical and Translational Medicine, 2020
- An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin ResistanceCell Metabolism, 2020
- Blocking the IL-1β signalling pathway prevents chronic viral myocarditis and cardiac remodelingBasic Research in Cardiology, 2019
- Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion InjuryCell Metabolism, 2017
- Prohibitin 2 Is an Inner Mitochondrial Membrane Mitophagy ReceptorCell, 2017
- Inflammasome Complexes: Emerging Mechanisms and Effector FunctionsCell, 2016